This new PDF report co-created by YSEOP and Emerj Artificial Intelligence Research explores what it means to bring AI and NLG to clinical study reports.
The report also explores how AI might streamline the drug discovery process itself. Topics discussed include:
- Trends contributing to digital transformation in pharma
- AI applications for speeding up the approval process
- A case study of Sanofi’s adoption of AI for drug discovery